Retinoblastoma Treatment: Utilization of the Glycolytic Inhibitor, 2-deoxy-2-fluoro-<scp>d</scp>-glucose (2-FG), to Target the Chemoresistant Hypoxic Regions in LH<sub>BETA</sub>T<sub>AG</sub>Retinal Tumors
Investigative Ophthalmology & Visual Science2012cited by 14position: firstdoi